Alternatives to edoxaban
2 same-class SPL records vs edoxaban - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Savaysa
About edoxaban
Savaysa is a medicine that helps to prevent blood clots. It is used to lower the chance of stroke in people with an irregular heartbeat (atrial fibrillation) and to treat blood clots in the legs or lungs.
Used for: Savaysa is used to lower the risk of stroke and blood clots in people with nonvalvular atrial fibrillation, a type of irregular heartbeat. It is also used to treat blood clots in the deep veins of your legs (DVT) or in your lungs (PE). You will likely need to take another medicine to prevent blood clots for 5 to 10 days before starting Savaysa for DVT or PE.
2 Direct Oral Anticoagulant (Factor Xa Inhibitor) peers (wide set)
apixaban
RxEliquis
Apixaban is used to lower the chance of stroke in people with an irregular heartbeat called atrial fibrillation. It also prevents blood clots in the legs (deep vein thrombosis or DVT) that can happen after hip or knee replacement surgery. Apixaban is also used to treat DVT and lung clots (pulmonary embolism or PE), and to prevent them from coming back.
rivaroxaban
RxXarelto
This medicine can help prevent strokes in people with an irregular heartbeat called atrial fibrillation. It also treats blood clots in the legs (deep vein thrombosis or DVT) and lungs (pulmonary embolism or PE). Rivaroxaban can also lower the risk of these clots coming back. It is also used to prevent blood clots after hip or knee replacement surgery and in acutely ill patients.
edoxaban peer mix vs class inventory
Peer mix
0 OTC and 2 Rx SPL records in this peer set (2 total). Class inventory for Direct Oral Anticoagulant (Factor Xa Inhibitor): 3 drugs.
Frequently Asked Questions
What same-class SPL records sit beside edoxaban? ▼
Reading a wide Direct Oral Anticoagulant (Factor Xa Inhibitor) peer set (2 records)
edoxaban (Savaysa) sits in a wide Direct Oral Anticoagulant (Factor Xa Inhibitor) peer set (2 of 2 class peers shown). Labeled indication field for edoxaban: Savaysa is used to lower the risk of stroke and blood clots in people with nonvalvular atrial fibrillation, a type of irregular heartbeat.
FAERS top-reaction fields are thin or absent for edoxaban in this extract; peer cards still expose SPL indication and OTC/Rx flags.
Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for edoxaban: see also the generic vs brand label guide when reading Savaysa SPL strings.
Read our methodology - how this data is sourced, computed, and verified.